A UNIQUE IMMUNOPHENOTYPE (IP) DEFINES CASES OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) WITH CHROMOSOME-11Q23 ABNORMALITIES AND POOR OUTCOME - A PEDIATRIC ONCOLOGY GROUP (POG) STUDY

被引：0
|
作者：
BOROWITZ, MJ
CARROLL, AJ
SHUSTER, JJ
BEHM, FG
PULLEN, DJ
FRANKEL, L
CRIST, WM
LAND, V
机构：
[1] DUKE UNIV,DURHAM,NC 27706
[2] POG,ST LOUIS,MO
来源：
LABORATORY INVESTIGATION | 1991年 / 64卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A68 / A68
页数：1
相关论文
共 50 条
  • [31] IMMUNOLOGICAL AND CLINICOPATHOLOGICAL FEATURES OF COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA ANTIGEN-POSITIVE CHILDHOOD T-CELL LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY
    DOWELL, BL
    BOROWITZ, MJ
    BOYETT, JM
    PULLEN, DJ
    CRIST, WM
    QUDDUS, FF
    RUSSELL, EC
    FALLETTA, JM
    METZGAR, RS
    CANCER, 1987, 59 (12) : 2020 - 2026
  • [32] THE T(1-14)(P34-Q11) IS NONRANDOM AND RESTRICTED TO T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY
    CARROLL, AJ
    CRIST, WM
    LINK, MP
    AMYLON, MD
    PULLEN, DJ
    RAGAB, AH
    BUCHANAN, GR
    WIMMER, RS
    VIETTI, TJ
    BLOOD, 1990, 76 (06) : 1220 - 1224
  • [33] TRANSITIONAL PRE-B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD IS ASSOCIATED WITH FAVORABLE PROGNOSTIC CLINICAL-FEATURES AND AN EXCELLENT OUTCOME - A PEDIATRIC-ONCOLOGY-GROUP STUDY
    KOEHLER, M
    BEHM, FG
    SHUSTER, J
    CRIST, W
    BOROWITZ, M
    LOOK, AT
    HEAD, D
    CARROLL, AJ
    LAND, V
    STEUBER, P
    PULLEN, DJ
    LEUKEMIA, 1993, 7 (12) : 2064 - 2068
  • [34] CLINICAL-FEATURES AND OUTCOME OF T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD WITH RESPECT TO ALTERATIONS AT THE TAL1 LOCUS - A PEDIATRIC ONCOLOGY GROUP-STUDY
    BASH, RO
    CRIST, WM
    SHUSTER, JJ
    LINK, MP
    AMYLON, M
    PULLEN, J
    CARROLL, AJ
    BUCHANAN, GR
    SMITH, RG
    BAER, R
    BLOOD, 1993, 81 (08) : 2110 - 2117
  • [35] DEOXYCOFORMYCIN TREATMENT FOR CHILDHOOD T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA EARLY IN 2ND REMISSION - A PEDIATRIC ONCOLOGY GROUP-STUDY
    WINICK, N
    BUCHANAN, GR
    MURPHY, SB
    YU, A
    BOYETT, J
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (05): : 327 - 332
  • [36] Significance of cytogenetic findings in childhood acute lymphoblastic leukemia (ALL) at first marrow relapse. A pediatric oncology group (FOG) study.
    Farah, RA
    Billett, AL
    Pollock, BH
    Buchanan, GR
    Schneider, NR
    BLOOD, 1997, 90 (10) : 818 - 818
  • [37] Acute lymphoblastic leukemia (ALL) with an unusual translocation, t(8;14)(q11.2;q32): A pediatric oncology group study.
    Kaleem, Z
    Shuster, JJ
    Carroll, AJ
    Borowitz, MJ
    Pullen, DJ
    Camitta, BM
    Zutter, MM
    Watson, MS
    BLOOD, 1998, 92 (10) : 398A - 398A
  • [38] A PHASE-II STUDY OF COMBINED METHOTREXATE AND TENIPOSIDE INFUSIONS PRIOR TO REINDUCTION THERAPY IN RELAPSED CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY
    OCHS, J
    RODMAN, J
    ABROMOWITCH, M
    KAVANAGH, R
    HARRIS, M
    YALOWICH, J
    RIVERA, GK
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (01) : 139 - 144
  • [39] New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group report of 343 cases
    Schneider, NR
    Carroll, AJ
    Shuster, JJ
    Pullen, DJ
    Link, MP
    Borowitz, MJ
    Camitta, BM
    Katz, JA
    Amylon, MD
    BLOOD, 2000, 96 (07) : 2543 - 2549
  • [40] EVALUATION OF HIGH-DOSE ARA-C (HDA) IN TREATMENT OF CHILDHOOD T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA (T-ALL) AND ADVANCED-STAGE LYMPHOBLASTIC NON-GROUP (POG) STUDY
    KATZ, JA
    AMYLON, MA
    RAVINDRANATH, Y
    SHUSTER, JJ
    BLOOD, 1994, 84 (10) : A145 - A145
12345